Polypill remains the only panacea in sight for cardiovascular disease, trial organiser says.
Nigel
N
Hawkes
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004338:Drug Combinations; D005492:Folic Acid / Q000008:administration & dosage; D006801:Humans; D019338:Polypharmacy
D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D004338:Drug Combinations; D005492:Folic Acid; D001241:Aspirin